May 2024 Gabapentin: Highlights and Challenges
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
Mental illness is common in the United States, with an estimated 52.9 million people – about 1 in 5 adults...
Healthcare providers rely on medication adherence test results to assist in measuring compliance and evaluating recent substance use. Providers must...
Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill), the cannabis industry has seen widespread growth in...